Publication | Closed Access

Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel disease

InflammationAnti-inflammatoryGastrointestinal PharmacologyMedicineImmune RegulationGastroenterologyChronic InflammationImmunologyMouse Colitis ModelHuman Blood CellsUlcerative ColitisPharmacologyInflammatory DiseaseDigestive System Diseases